Sexually Transmitted DiseasesNCT04372485
Using Mobile Health (mHealth) to Improve STI Treatment Adherence Among Adolescents
A study testing mHealth Intervention in people with Sexually Transmitted Diseases, run by Children's National Research Institute at 1 site in United States.
Trial summary
We will conduct a randomized trial to compare differences in sexually transmitted infection (STI) treatment adherence between patients receiving text messages versus those receiving usual care (e.g. no text messages). Read more about this study
- Who is it for?
- Ages 15 to 21 years
- Conditions the study is for
- Sexually Transmitted Diseases
- What is being tested?
- mHealth Intervention
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 270 participants
- Where
- 1 siteUnited States
- Study dates
- 3 Jun 2024to Jun 2027
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 15 to 21 years
- All sexes
- No healthy volunteers
- Child, Adult
Who may be able to join
- Adolescent patients seen in the Emergency Department who test positive for gonorrhea, chlamydia, or pelvic inflammatory disease and are prescribed outpatient antibiotic treatment.
Who cannot join
- Patients will be excluded if they are unable to understand English, are critically ill, have cognitive impairment or if they do not have access to a cellular telephone with text messaging capabilities.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
Children's National Hospital
Washington D.C., District of Columbia, 20016-1838
Monika Goyal, 2024762869, mgoyal@cnmc.org
About this study
Official title: Leveraging Health Information Technology to Reduce Health Disparities in Adolescent Health Outcomes: A Patient-Centered Approach
We will conduct a randomized trial to compare differences in sexually transmitted infection (STI) treatment adherence between patients receiving text messages versus those receiving usual care (e.g. no text messages). We hypothesize that STI treatment adherence will be 20% higher among patients randomized to receipt of two-way text messaging services.
- Conditions
- Sexually Transmitted Diseases
- Being tested
- mHealth Intervention
- Medical subject headings
- Sexually Transmitted Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
mHealth InterventionBehavioural
Adolescents will receive text messages to facilitate treatment adherence
| Study group | Role | What they receive |
|---|---|---|
| mHealth | Other | Adolescents enrolled in this arm will receive treatment-related text messages. Receives: Behavioral: mHealth Intervention |
| Usual care | No intervention | Adolescents in this arm will receive usual care. |
What is being measured
The primary outcome is the main question the study is designed to answer.
STI treatment adherence
Proportion of study participants who complete their medication as prescribed by self-report
Measured: 1-21 days after prescription filling
Secondary outcomes (1)
STI treatment receipt
Proportion of study participants who receive STI treatment; measured by prescription filling and/or receiving treatment at a healthcare facility
Measured: 1-21 days after STI diagnosis
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 May 2020
- Study start3 Jun 2024
- Primary completionJun 2027 (estimated)
- Study completionJun 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Sexually Transmitted DiseasesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 270 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Children's National Research Institute
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Monika Goyal, Children's National Research Institute
- Investigators
- Monika Goyal, Principal investigator, Children's National Research Institute
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04372485
- Sponsor's protocol ID
- Pro0001427
- Status last verified
- Oct 2026
- First submitted
- 30 Apr 2020
- Last updated
- 22 Oct 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No